/PRNewswire/ - Specific Biologics Inc. ("Specific"), a venture-backed, early-stage genome editing company, is pleased to announce it has appointed Tirtha.
In the quest to uncover the origins for SARS-CoV-2, scientists did not have to look very far. For years, the National Institutes of Health, in cooperation with EcoHealth Alliance and the [.]
On February 23 the Daily Mail ran an article showing that Moderna has patented the 19 base letter (nucleotide) sequence which codes for the Furin Cleavage site in Covid-19. (Article republished [.]
Evidence has emerged which proves beyond a reasonable doubt that the pharmaceutical giant Moderna, the company that has made billions through the sale of an experimental Covid-19 injection, [.]